NDC 70518-2780-1 - Naloxone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2780
- Requested NDC
- 70518-2780-1
- Package NDCs from labels
- 70518-2780-1, 70518-2780-0
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2022-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naloxone Hydrochloride - REMEDYREPACK INC. | REMEDYREPACK INC. | 2022-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70518-2780-0 | 2022-02-02 | C162847 | 48780-1 | d6a99b39-47e2-a426-e053-dadaa90af4c2 | 4838e624-7b53-4e45-b42c-ef1213507188 |
| 70518-2780-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-47e2-a426-e053-dadaa90af4c2 | 4838e624-7b53-4e45-b42c-ef1213507188 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | A-S Medication Solutions | 0b3b5214-6f91-4bba-82d6-d57b16845df5 | 2023-10-01 | Warnings, Adverse reactions | F850569PQR |
| NARCAN | NALOXONE HYDROCHLORIDE | A-S Medication Solutions | 139c30b9-5600-48f5-8610-0cacd2782398 | 2023-09-28 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | b598c237-032d-4bb5-0e92-50eabd863dac | 2023-06-04 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | A-S Medication Solutions | 3d2dcee4-7510-477b-95a8-9b2afb773984 | 2023-05-23 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 958577c3-d2c4-26ad-e053-2a95a90ad73a | 2023-05-15 | Warnings, Adverse reactions | ANDA072076 1191250 F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 9e53f169-4a6e-6102-e053-2995a90ab3dc | 2023-05-09 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ada6856c-5293-fc2f-e053-2995a90a8ec6 | 2023-05-03 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | b621239f-0bbb-7d07-e053-2a95a90a287e | 2023-04-26 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 8959171f-eda6-158c-e053-2995a90a36b2 | 2023-04-26 | Warnings, Adverse reactions | F850569PQR |
| naloxone hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | fa1ca55b-f56b-0d9b-e053-6294a90a258a | 2023-04-24 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ea4ea2fe-af48-0b3c-e053-2a95a90a0ad5 | 2023-04-24 | Warnings, Adverse reactions | ANDA072076 1191250 F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | f9c5efca-443a-41a0-e053-6294a90a8774 | 2023-04-20 | Warnings, Adverse reactions | 1191250 F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co. LLC, DBA HealthFirst | 74fcd243-94b3-ec77-e053-2991aa0a229c | 2022-12-09 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Proficient Rx LP | 8d529b4c-85fd-4e50-9443-9080825307bf | 2022-10-01 | Warnings, Adverse reactions | F850569PQR |
| Narcan | NALOXONE HYDROCHLORIDE | Proficient Rx LP | 76b5a1ce-e601-457c-ab35-43533bba4394 | 2022-08-01 | Warnings, Adverse reactions | F850569PQR |
| e4dd2392-293d-0deb-e053-2995a90abd3f | 4838e624-7b53-4e45-b42c-ef1213507188 | 2022-07-28 | Warnings, Adverse reactions | 4838e624-7b53-4e45-b42c-ef1213507188 | ||
| Naloxone Hydrochloride Injection, USP, Auto-Injector | NALOXONE HYDROCHLORIDE | Kaleo, Inc. | b5463553-b775-47a3-8d10-31e01ca1ec72 | 2022-03-11 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | International Medication Systems, Limited | d2f5bfa0-933e-46d0-8b1a-9f90e6aaba54 | 2021-12-13 | Warnings, Adverse reactions | ANDA072076 76329-3469 1191250 2ab20a74-a067-4d43-84fb-fe331192c34b d2f5bfa0-933e-46d0-8b1a-9f90e6aaba54 F850569PQR |
| naloxone hydrochloride | NALOXONE HYDROCHLORIDE | Baxter Healthcare Corporation | d04ae2d7-01b9-405d-bb7a-bf2d876ce26a | 2021-07-02 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Mylan Institutional LLC | d96ebf2e-1051-4b5b-b1c6-2543dbbb2d04 | 2021-04-21 | Warnings, Adverse reactions | F850569PQR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.